The Utility of the Pirche-ii Score in Risk-Stratifying Simultaneous Liver-Kidney Transplant Recipients with Preformed Donor-Specific Anti-hla Antibodies

被引：0
|
作者：
Abu Jawdeh, B. G. [1 ]
Khamash, H. [1 ]
Budhiraja, P. [1 ]
Jaramillo, A. [1 ]
Hacke, K. [1 ]
Buras, M. [1 ]
Rios, I. [1 ]
Akin, D. E. [1 ]
Van der Walt, C. S. [1 ]
Kodali, L. [1 ]
Aqel, B. [1 ]
机构：
[1] Mayo Clin, Phoenix, AZ USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B217
引用
收藏
页码：S853 / S854
页数：2
相关论文
共 50 条
  • [1] Impact of Preformed, Donor-Specific, Anti-HLA Antibodies on Combined Liver Kidney Transplant Outcome
    Mandal, Saptarshi
    Du, Zeying
    Weidner, Jerome
    Ramahi, Sana
    Kunnavakkam, Rangesh
    Te, Helen
    Marino, Susana R.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (03) : 506 - 506
  • [2] THE ROLE OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN LIVER TRANSPLANT RECIPIENTS
    Uenlue, S.
    Lachmann, N.
    Jara, M.
    Ritschl, P. V.
    Weiss, S.
    Chopra, S.
    Denecke, C.
    Gerlach, U.
    Eurich, D.
    Pratschke, J.
    Oelinger, R.
    [J]. TRANSPLANT INTERNATIONAL, 2018, 31 : 12 - 12
  • [3] DE NOVO DEVELOPMENT OF ANTI-HLA ANTIBODIES IN LUNG TRANSPLANT RECIPIENTS WITH PREEXISTING DSA IS RELATED TO PIRCHE-II SCORE
    Lobashevsky, Andrew L.
    Niemann, Matthias
    Kowinsk, Brenda
    Higgins, Nancy G.
    Roe, David W.
    Hage, Chadi
    [J]. HUMAN IMMUNOLOGY, 2019, 80 : 147 - 147
  • [4] Anti-HLA antibodies monitoring in kidney transplant recipients: high prevalence of donor specific anti-HLA class II antibodies
    Ares, O. M.
    Ruiz, A. T.
    Tagarro, E. F.
    Samper, R. G.
    Rodriguez, R. G.
    Palop, F. H.
    Valentin, M. A. P.
    Estupinan, R. S.
    Perez, J. C. R.
    Andres, M. D. C.
    [J]. IMMUNOLOGY, 2012, 137 : 736 - 737
  • [5] Adherence of Immunosuppression Therapy and Donor-specific anti-HLA antibodies in the Pediatric Liver Transplant Recipients
    Yoshizawa, Atsushi
    Kaneshiro, Masakatsu
    Uebayashi, Elena
    Suzuki, Kumiko
    Ogawa, Eri
    Okamoto, Shinya
    Okajima, Hideaki
    Kaido, Toshimi
    Haga, Hironori
    Uemoto, Shinji
    [J]. TRANSPLANTATION, 2018, 102 : S879 - S879
  • [6] EVALUATION OF HLA ANTIBODIES IN DECEASED DONOR SIMULTANEOUS LIVER-KIDNEY TRANSPLANT RECIPIENTS
    Walsh, R. Carlin
    Levitsky, Joshua
    Zitzner, Jennifer R.
    Tambur, Anat R.
    [J]. HUMAN IMMUNOLOGY, 2013, 74 : 43 - 43
  • [7] CHARACTERISTICS OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS.
    Ghandorah, Salim
    Yilmaz, Serdar
    Abadi, Abdulnaser
    Rahmanian, Taleb
    Wang, Jinguo
    Khan, Faisal M.
    Berka, Noureddine
    [J]. HUMAN IMMUNOLOGY, 2015, 76 : 163 - 163
  • [8] Belatacept in Kidney Transplant Recipients with Preformed Donor Specific Anti-HLA Antibodies: Results of the BELACOR Trial.
    Leibler, C.
    Canoui, F.
    Matignon, M.
    Rondeau, E.
    Zarour, A.
    Durrbach, A.
    Malard, S.
    Grimbert, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 293 - 293
  • [9] Donor-specific anti-HLA antibody mediated rejection in liver transplant recipients
    Dziodzio, Tomasz
    Lachmann, Nils
    Uenlue, Sinem
    Weiss, Sascha
    Chopra, Sascha
    Guel, Safak
    Gerlach, Undine
    Denecke, Christian
    Biebl, Matthias
    Schonemann, Constanze
    Pratschke, Johann
    Oellinger, Robert
    [J]. TRANSPLANTATION, 2016, 100 (07) : S244 - S244
  • [10] WHICH PREFORMED DONOR-SPECIFIC ANTI-HLA ANTIBODIES ARE CLINICALLY RELEVANT?
    Salvade, Igor
    Aubert, Vincent
    Venetz, J. P.
    Golshayan, Dela
    Sugamele, Rocco
    Gregoretti, Stephanie
    Pantaleo, Giuseppe
    Pascual, Manuel
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 70 - 71
12345